To assess whether STAT6 inhibition-induced iTregs (AS-iTregs) could exert excessive immunosuppression or promote tumor growth, we compared the effects of adoptively transferred control iTregs and AS-iTregs in the AOM/DSS-induced colitis-associated cancer (CAC) model (Fig. 5A). The gene discussed is STAT6; the disease is neoplasm.